Is furosemide (Lasix) beneficial in the management of rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Will Lasix Help in Rhabdomyolysis?

No, furosemide (Lasix) should not be used to treat or prevent acute kidney injury in rhabdomyolysis—its only role is managing volume overload if it develops during aggressive fluid resuscitation. 1


Why Furosemide Is Not Recommended

The KDIGO guidelines explicitly state that diuretics should not be used to prevent AKI (Grade 1B) or to treat AKI (Grade 2C), except when managing established volume overload. 1 Randomized controlled trials and meta-analyses demonstrate that furosemide does not prevent AKI and may actually increase mortality when used for this purpose. 1

In rhabdomyolysis specifically, the cornerstone of treatment is aggressive intravenous fluid resuscitation (IVFR) to maintain high urine output (>200–300 mL/hour) and prevent myoglobin-induced tubular injury. 2, 3, 4 Adding furosemide does not improve renal outcomes and risks precipitating volume depletion, hypotension, and further renal hypoperfusion—exactly what you are trying to avoid. 1


The Evidence Against Diuretics in Rhabdomyolysis

  • Aggressive IVFR decreases the incidence of acute renal failure and need for dialysis in patients with rhabdomyolysis (conditional recommendation, very low-quality evidence). 2
  • Neither bicarbonate nor mannitol administration improved outcomes in rhabdomyolysis, and the same principle applies to furosemide—there is no evidence supporting its use to prevent or treat AKI in this setting. 2
  • The McMahon score is useful for identifying patients at highest risk for serious complications, but the treatment remains crystalloid resuscitation, not diuretics. 4, 5

The Only Indication for Furosemide in Rhabdomyolysis

If volume overload develops during aggressive fluid resuscitation (e.g., pulmonary edema, rising jugular venous pressure, declining oxygen saturation), furosemide may be used to manage the fluid overload—but only if systolic blood pressure is ≥90–100 mmHg and the patient is not anuric. 1, 6

  • Start with 20–40 mg IV furosemide administered slowly over 1–2 minutes. 6
  • Monitor urine output hourly (target >0.5 mL/kg/hour) and check electrolytes within 6–24 hours. 6
  • If diuresis is inadequate after 2 hours, double the dose, but do not exceed 160–200 mg per bolus. 6
  • Stop furosemide immediately if systolic BP drops <90 mmHg, severe hyponatremia (Na <120–125 mmol/L), severe hypokalemia (K <3 mmol/L), or anuria develops. 6

Common Pitfalls to Avoid

  • Do not give furosemide expecting it to improve renal function or "flush out" myoglobin—this is a dangerous misconception. Furosemide does not treat AKI; it only manages volume overload. 1
  • Do not administer furosemide to hypotensive patients—it will worsen tissue perfusion and precipitate cardiogenic shock. 6
  • Do not withhold aggressive IVFR out of fear of volume overload—the primary treatment for rhabdomyolysis is high-volume crystalloid resuscitation (often 10–15 liters in the first 24 hours), and furosemide should only be added if clinical signs of overload appear. 2, 3, 4
  • Furosemide itself can cause rhabdomyolysis when combined with certain drugs (e.g., bezafibrate) or in the setting of severe hypokalemia from bulimia or laxative abuse. 7, 8 Long-term furosemide use has also been associated with acute renal failure and myoglobinuria in patients with idiopathic edema. 9

Practical Algorithm for Rhabdomyolysis Management

  1. Initiate aggressive IVFR with isotonic crystalloid (normal saline or lactated Ringer's) at 10–15 mL/kg/hour to maintain urine output >200–300 mL/hour. 2, 3, 4
  2. Monitor for volume overload (pulmonary crackles, rising JVP, declining SpO₂, weight gain >1 kg/day). 6
  3. If volume overload develops and SBP ≥90–100 mmHg, give furosemide 20–40 mg IV and titrate to maintain urine output while avoiding further overload. 6
  4. If AKI progresses despite maximal medical therapy, consider renal replacement therapy (RRT)—not furosemide escalation. 1, 2
  5. Monitor electrolytes (especially potassium, calcium, phosphate) and renal function every 6–24 hours during the acute phase. 10, 3, 4

Key Takeaway

Furosemide has no role in preventing or treating AKI in rhabdomyolysis. The treatment is aggressive fluid resuscitation, and furosemide should only be used if volume overload complicates the resuscitation effort. 1, 2, 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.